Natural history of nonketotic hyperglycinemia in 65 patients

Neurology

Volumn 63, Issue 10, 2004, Pages 1847-1853

  Hoover Fong, J E ^a,b   Shah, S ^b   Van Hove, J L K ^c   Applegarth, D ^d   Toone, J ^d   Hamosh, Ada ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CORPUS CALLOSUM; DISEASE ASSOCIATION; DISEASE COURSE; EPILEPSY; FEMALE; HUMAN; HYDROCEPHALUS; HYPERGLYCINEMIA; LANGUAGE DEVELOPMENT; MALE; MORTALITY; PRIORITY JOURNAL; WALKING;

EID: 8844270815     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000144270.83080.29     Document Type: Article

References (14)

1. Hamosh A, Johnston M. Nonketotic hyperglycinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 11th ed. New York: McGraw-Hill, 2001:2065-2078.
2. Tada K. Nonketotic hyperglycinemia. In: Fernandes J, Saudubray JM, Van den Berghe G, eds. Inborn metabolic diseases, 3rd ed. Berlin: Springer, 2000:254-258.
3. Aliefendiouglu D, Aslan AT, Coskum T, Dursun A, Cakmak FN, Kesimer M. Transient nonketotic hyperglycinemia: two case reports and literature review. Pediatr Neurol 2003;28:151-155.
4. Chatterton JE, Awobuluyi M, Premkumar LS, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2003;415:793-798.
5. van der Knaap MS, Wevers RA, Kure S, et al. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol 1999;14:728-731.
6. Toone JR, Applegarth DA, Kure S, et al. Novel mutations in the P-protein (glycine decarboxylase) gene in patients with glycine encephalopathy (non-ketotic hyperglycinemia). Mol Genet Metab 2002;76:243-249.
7. Toone JR, Applegarth DA, Levy HL. Molecular genetic and potential biochemical characteristics of patients with protein deficiency as a cause of glycine encephalopathy (NKH). Mol Genet Metab 2002;79:272-280.
8. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000;105:e10.
9. Wendt LV, Hirvas A, Simila S. Nonketotic hyperglycinemia: a genetic study of 13 Finnish families. Clin Genet 1979;15:411-417.
10. Warburton D, Boyle RJ, Keats JP, Vohr B, Peuschel S, Oh W. Nonketotic hyperglycinemia. Am J Dis Child 1980;134:273-275.
11. Van Hove JLK, Kishnani PS, Demaerel P, et al. Acute hydrocephalus in nonketotic hyperglycinemia. Neurology 2000;54:754-756.
12. Hamosh A, Maher JF, Bellus GA, et al. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998;132:709-713.
13. Korman SH, Gutman A. Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia). Dev Med Child Neurol 2002;44:712-720.
14. Carson NAJ for NKH Workshop. 17th Symposium of SSIEM. Non-ketotic hyperglycinaemia-a review of 70 patients. J Inner Metab Dis 1982;5(suppl 2):126-128.